Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data solutions ...
The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...
Medical equipment maker Thermo Fisher is nearing an all-cash takeover of U.S-based Clario in a deal that could value the ...
Thermo Fisher Scientific Inc. (NYSE: TMO) announced AI utilization plans with OpenAI in a collaboration intended to improve ...